会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Polyamino acids functionalised with at least one hydrophobic group and applications thereof particularly therapeutic applications
    • 用至少一个疏水基团官能化的聚氨基酸及其应用特别是治疗应用
    • US07919572B2
    • 2011-04-05
    • US10558617
    • 2004-05-28
    • Stéphanie AngotOlivier BreyneYou-Ping Chan
    • Stéphanie AngotOlivier BreyneYou-Ping Chan
    • C08G69/10A01N25/00A61K47/00
    • A61K8/88A61K47/645A61K2800/57A61Q19/00C08G69/10C08G69/48
    • The invention relates to novel materials based on biodegradable polyamino acids, particularly useful for the vectorisation of active principals (PA). The invention further relates to novel, pharmaceutical, cosmetic, dietary or phytosanitary compositions. The invention provides novel polymeric raw material, for use in the vectorisation of PA and with an optimal match for all the requirements of the type: biocompatibility, biodegradability, stability, ability to easily associate with numerous active principals or to solubilise the same and to liberate said active principals in vivo. Said aim is achieved with polyamino acids comprising aspartic and/or glutamate units, some of which carry at least one graft, characterised in that at least one of said grafts is bonded to an aspartic or glutamate unit by means of an amino acids spacer based on Leu, and/or Ileu, and/or Val, and/or Phe and a hydrophobic group with C6-C30 is connected by an ester bond to the spacer.
    • 本发明涉及基于可生物降解的聚氨基酸的新型材料,特别适用于活性成分(PA)的向量化。 本发明进一步涉及新的,药物,化妆品,膳食或植物检疫组合物。 本发明提供新颖的聚合物原料,用于PA的载体化和与所有类型的所有要求的最佳匹配:生物相容性,生物可降解性,稳定性,容易与许多活性成分相关联或溶解它并释放的能力 活体检者在体内表示。 所述目的通过包含天冬氨酸和/或谷氨酸单体的聚氨基酸实现,其中一些氨基酸携带至少一个接枝物,其特征在于至少一个所述移植物通过氨基酸间隔基与天冬氨酸或谷氨酸单元结合,基于 Leu和/或Ileu和/或Val,和/或Phe和具有C6-C30的疏水基团通过酯键连接到间隔物上。
    • 2. 发明授权
    • Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications
    • 由α-生育酚功能化的聚氨基酸及其用途,特别用于治疗应用
    • US07683024B2
    • 2010-03-23
    • US10516733
    • 2003-06-03
    • You-Ping ChanStéphanie AngotOlivier Breyne
    • You-Ping ChanStéphanie AngotOlivier Breyne
    • C07K38/02
    • A61K8/88A61K8/678A61K9/5146A61K47/34A61K2800/57A61Q19/00C08G69/10C08G69/48
    • The invention concerns novel biodegradable polyaminoacid materials, useful in particular for vectoring active principle(s). The invention also concerns novel pharmaceutical, cosmetic dietetic or phytosanitary compositions based on said polyaminoacids. The invention aims at providing a novel polymer raw material, capable of being used for vectoring active principles and enabling optimal fulfillment of all specified requirements: biocompatibility, biodegradability, easy and inexpensive transformation into particles vectoring active principles, the particles being themselves capable of forming colloidal suspensions, of being easily associated with numerous active principles, and of releasing said active principles in vivo. Therefor, the present invention concerns first of all amphiphilic polyaminoacids comprising aspartic acid units and/or glutamic acid units, characterized in that at least part of said units carry grafts, including at least one alpha-tocopherol motif, for example (polyglutamate or polyaspartate grafted with alpha-tocopherol of synthetic or natural origin).
    • 本发明涉及新型可生物降解的聚氨基酸材料,特别适用于向量活性成分。 本发明还涉及基于所述聚氨基酸的新型药物,美容饮食或植物检疫组合物。 本发明旨在提供一种新颖的聚合物原料,能够用于向导活性原理,并能够最佳地实现所有特定的要求:生物相容性,生物降解性,易于和便宜地转化成粒子的载体活性成分,颗粒本身能够形成胶体 悬浮液,易于与许多活性成分相关联,并且在体内释放所述活性成分。 因此,本发明涉及包含天冬氨酸单元和/或谷氨酸单元的所有两亲性聚氨基酸的首要问题,其特征在于所述单元的至少一部分携带移植物,包括至少一种α-生育酚基序,例如(聚谷氨酸或聚天冬氨酸嫁接 合成或天然来源的α-生育酚)。
    • 3. 发明授权
    • Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof
    • 由至少一个疏水基团官能化的聚氨基酸及其治疗应用
    • US07678882B2
    • 2010-03-16
    • US11509783
    • 2006-08-25
    • Stéphanie AngotOlivier BreyneYou-Ping ChanGérard Soula
    • Stéphanie AngotOlivier BreyneYou-Ping ChanGérard Soula
    • C07K2/00
    • A61Q19/00A61K8/88A61K47/34A61K47/645A61K47/65C08G69/10C08G69/48
    • The invention relates to novel materials based on biodegradable polyamino acids that are useful for vectorizing active principle(s)(AP). The aim of the invention is to supply a new polymeric raw material that is used for vectorizing AP and optimally fulfills all requirements concerning biocompatibility, biodegradability, the ability to be easily associated with numerous active principles or solubilize the active principles and to release the active principles in vivo. Such polymers can also be readily and economically transformed into particles vectorizing active principles according to the grafting rate of the hydrophobic groups, said particles being able to form stable aqueous colloidal suspensions. The aim of the invention is achieved by the inventive amphiphile polyamino acids comprising aspartic and/or glutamic units that carry grafts which encompass at least one hydrophobic unit and are linked to the aspartic and/or glutamic units via a rotula containing two amide functions, more particularly via a spacer of the lysine or ornithine type. The amide functions ensure better stability during hydrolysis than comparable products known in prior art. The invention also relates to new pharmaceutical, cosmetic, dietetic, or phytosanitary compositions based on the inventive polyamino acids.
    • 本发明涉及可用于向量化活性成分(AP)的可生物降解的聚氨基酸的新型材料。 本发明的目的是提供一种新的聚合物原料,其用于向AP进行载体化,并且最佳地满足关于生物相容性,生物可降解性,易于与许多活性成分相关联或增溶活性成分的能力的所有要求,并释放活性成分 体内。 这样的聚合物也可以容易地和经济地转化成根据疏水基团的接枝速率向量化活性成分的颗粒,所述颗粒能够形成稳定的水性胶态悬浮液。 本发明的目的是通过包含天冬氨酸和/或谷氨酸单元的本发明的两亲性聚氨基酸实现的,所述天然氨基酸和/或谷氨酸单元携带包含至少一个疏水单元的移植物,并通过含有两个酰胺官能团的转运体与天冬氨酸和/或谷氨酸单元连接 特别是通过赖氨酸或鸟氨酸类型的间隔物。 酰胺功能确保在水解期间比现有技术中已知的可比产品更好的稳定性。 本发明还涉及基于本发明的聚氨基酸的新的药物,化妆品,饮食或植物检疫组合物。
    • 4. 发明申请
    • POLYAMINOACIDS FUNCTIONALIZED WTIH ALPHA-TOCOPHEROL, AND USES THEREOF, ESPECIALLY THERAPEUTIC USES
    • 聚氨基甲酸酯功能性维生素A和其用途,特别是治疗用途
    • US20100048735A1
    • 2010-02-25
    • US12581644
    • 2009-10-19
    • You-Ping ChanStéphanie AngotOlivier Breyne
    • You-Ping ChanStéphanie AngotOlivier Breyne
    • A61K47/34C08G73/10A61P43/00
    • A61K8/88A61K8/678A61K9/5146A61K47/34A61K2800/57A61Q19/00C08G69/10C08G69/48
    • The invention concerns novel biodegradable polyaminoacid materials, useful in particular for vectoring active principles(s). The invention also concerns novel pharmaceutical, cosmetic dietetic or phytosanitary compositions based on said polyaminoacids. The invention aims at providing a novel polymer raw material, capable of being used for vectoring active principles and enabling optimal fulfillment of all specified requirements: biocompatibility, biodegradability, easy and inexpensive transformation into particles vectoring active principles, said particles being themselves capable of forming colloidal suspensions, of being easily associated with numerous active principles, and of releasing said active principles in vivo. Therefor, the present invention concerns first of all amphiphilic polyaminoacids comprising aspartic acid units and/or glutamic acid units, characterized in that at least part of said units carry grafts, including at least one alphα-tocopherol motif, for example (polyglutamate or polyaspartate grafted with alphα-tocopherol of synthetic or natural origin).
    • 本发明涉及新颖的可生物降解的聚氨基酸材料,特别适用于载体活​​性成分。 本发明还涉及基于所述聚氨基酸的新型药物,美容饮食或植物检疫组合物。 本发明旨在提供一种新颖的聚合物原料,其能够用于向量活性成分的原理并且能够最佳地实现所有特定的要求:生物相容性,生物降解性,容易且便宜的转化成粒子的载体活性成分,所述颗粒本身能够形成胶体 悬浮液,易于与许多活性成分相关联,并且在体内释放所述活性成分。 因此,本发明涉及包含天冬氨酸单元和/或谷氨酸单元的所有两亲性聚氨基酸的首要问题,其特征在于至少部分所述单元携带移植物,包括至少一种α-α-生育酚基序,例如(聚谷氨酸或聚天冬氨酸酯接枝 合成或天然来源的α-生育酚)。
    • 6. 发明申请
    • Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof
    • 由至少一个疏水基团官能化的聚氨基酸及其治疗应用
    • US20070160568A1
    • 2007-07-12
    • US11509783
    • 2006-08-25
    • Stephanie AngotOlivier BreyneYou-Ping ChanGerard Soula
    • Stephanie AngotOlivier BreyneYou-Ping ChanGerard Soula
    • A61K38/16A61K31/785C07K14/47
    • A61Q19/00A61K8/88A61K47/34A61K47/645A61K47/65C08G69/10C08G69/48
    • The invention relates to novel materials based on biodegradable polyamino acids that are useful for vectorizing active principle/s (AP). The aim of the invention is to supply a new polymeric raw material that is used for vectorizing AP and optimally fulfills all requirements concerning biocompatibility, biodegradability, the ability to be easily associated with numerous active principles or solubilize said active principles and to release the active principles in vivo. Said polymers can also be readily and economically transformed into particles vectorizing active principles according to the grafting rate of the hydrophobic groups, said particles being able to form stable aqueous colloidal suspensions. Said aim is achieved by the inventive amphiphile polyamino acids comprising aspartic and/or glutamic units that carry grafts which encompass at least one hydrophobic unit and are linked to the aspartic and/or glutamic units via a rotula containing two amide functions, more particularly via a spacer of the lysine or ornithine type. Said amide functions ensure better stability during hydrolysis than comparable products known in prior art. The invention also relates to new pharmaceutical, cosmetic, dietetic, or phytosanitary compositions based on the inventive polyamino acids.
    • 本发明涉及可用于向量化活性成分(AP)的可生物降解的聚氨基酸的新型材料。 本发明的目的是提供一种新的聚合物原料,其用于向AP进行载体化,并且最佳地满足关于生物相容性,生物可降解性,易于与许多活性成分相关联的能力或增溶所述活性成分并释放活性成分的所有要求 体内。 所述聚合物也可以容易地和经济地转化成根据疏水基团的接枝速率向量化活性成分的颗粒,所述颗粒能够形成稳定的水性胶体悬浮液。 所述目的通过包含天冬氨酸和/或谷氨酸单元的本发明的两亲性聚氨基酸实现,所述天然氨基酸和/或谷氨酸单元携带包含至少一个疏水单元的移植物,并且通过含有两个酰胺官能团的转运体连接到天冬氨酸和/或谷氨酸单元, 赖氨酸或鸟氨酸类型的间隔物。 所述酰胺功能确保在水解期间比现有技术中已知的可比产品更好的稳定性。 本发明还涉及基于本发明的聚氨基酸的新的药物,化妆品,饮食或植物检疫组合物。
    • 8. 发明授权
    • Telechelic homopolyamino acids functionalized with hydrophobic groups, and their applications, especially therapeutic applications
    • 用疏水基团官能化的远端电泳多聚氨基酸及其应用,特别是治疗应用
    • US07659365B2
    • 2010-02-09
    • US10574475
    • 2004-09-28
    • Rémi SoulaYou-Ping ChanGérard SoulaOlivier Breyne
    • Rémi SoulaYou-Ping ChanGérard SoulaOlivier Breyne
    • C07K14/00
    • A61K8/88A61K9/1075A61K9/5146A61K47/34A61K47/645A61Q19/00C08G69/10C08G73/028C08L79/02
    • The invention relates to novel materials based on biodegradable homopolyamino acids and which can be used for the vectorization of (an) active ingredient(s) (AI). The invention also relates to novel pharmaceutical, cosmetic, dietetic or phytosanitaty compositions based on homopolyamino acids. The invention can produce a novel polymer raw material which can be used for the vectoiization of Al that can optimally be: biocompatible, biodegradable, capable of becoming easily associated with a large number of active ingredients or solubilizing them and releasing the active ingredients in vivo. According to the present invention, which primarily relates to linear homopolyamino acids having aspartic or glutamic units and whose attachments can include hydrophobic groups having 8-30 carbon atoms. The homopolymers are amphiphilic and anionic and can easily be transformed at low cost into particles for the vectorization of active ingredients. The particles can form stable aqueous colloidal suspensions.
    • 本发明涉及基于可生物降解的均聚氨基酸的新型材料,其可用于(a)活性成分(AI)的向量化。 本发明还涉及基于均聚氨基酸的新型药物,化妆品,饮食或植物营养成分。 本发明可以生产出一种新型的聚合物原料,它可以用于最佳的生物相容性,生物降解性,能够容易地与大量活性成分缔合或溶解它们并在体内释放活性成分的Al的促进作用。 根据本发明,其主要涉及具有天冬氨酸或谷氨酸单元的线性均聚氨基酸,并且其连接物可以包括具有8-30个碳原子的疏水基团。 均聚物是两亲性的和阴离子的,并且可以容易地以低成本转化成用于活性成分载体化的颗粒。 颗粒可以形成稳定的水性胶体悬浮液。
    • 9. 发明申请
    • Self-precipitating pharmaceutical formulations for the moified release of an active principle
    • 用于释放活性成分的自沉淀药物制剂
    • US20090011028A1
    • 2009-01-08
    • US12149541
    • 2008-05-05
    • Frederic ChecotCecile Bonnet-GonnetYou-Ping ChanOlivier BreyneRemi Meyrueix
    • Frederic ChecotCecile Bonnet-GonnetYou-Ping ChanOlivier BreyneRemi Meyrueix
    • A61K47/42A61K9/10A61K38/20
    • A61K9/0019A61K9/10A61K9/1641A61K38/02A61K47/645A61K48/00
    • The present invention relates to novel pharmaceutical formulations for the release of an active principle (AP) over a sustained period of time of several days, or even several weeks.The invention relates, in a first aspect, to a liquid formulation comprising at least one active principle (AP) and an aqueous suspension based on colloïdal particles of a polymer (PO), wherein said formulation satisfies the following four conditions:(a) the polymer (PO) is a polyamino acid comprising glutamic residues, wherein some glutamic residues each carry a pendant cationic group (CG), said cationic groups being identical or different from one another, and other glutamic residues each carry a pendent hydrophobic group (GH), said hydrophobic groups (GH) being identical or different from one another, (b) the pHf value of the pH of said formulation is between 3.0 and 6.5; (c) at the pHf value, the polymer (PO) forms a colloïdal solution which associates spontaneously and noncovalently with the active principle (AP); (d) 1 ml of said formulation precipitates during mixing with a volume of 1 ml of a test buffer solution Tp. The invention also relates to a process for the preparation of such formulations and to a process for the preparation of medicaments including such formulations.
    • 本发明涉及用于在持续的几天甚至几周的时间内释放活性成分(AP)的新型药物制剂。 本发明在第一方面涉及包含至少一种活性成分(AP)和基于聚合物(PO)的胶体颗粒的水性悬浮液的液体制剂,其中所述制剂满足以下四个条件:(a) 聚合物(PO)是包含谷氨酸残基的聚氨基酸,其中一些谷氨酸残基各自携带阳离子基团(CG),所述阳离子基团彼此相同或不同,并且其它谷氨酸残基各自携带悬垂疏水基团(GH) ,所述疏水基团(GH)彼此相同或不同,(b)所述制剂的pH值的pHf值为3.0至6.5; (c)在pHf值下,聚合物(PO)形成一种自发和非共价结合活性成分(AP)的胶体溶液; (d)1ml所述制剂在与1ml测试缓冲溶液Tp的体积混合期间沉淀。 本发明还涉及一种制备这些制剂的方法以及制备包括这些制剂的药物的方法。